Insulet Corporation is a leading medical device company specializing in innovative insulin management systems for people with diabetes. Founded in 2000 and headquartered in Acton, Massachusetts, Insul... Insulet Corporation is a leading medical device company specializing in innovative insulin management systems for people with diabetes. Founded in 2000 and headquartered in Acton, Massachusetts, Insulet is renowned for its Omnipod system—a tubeless, wearable insulin pump that delivers continuous insulin without the need for multiple daily injections. The company’s products enhance diabetes care by simplifying insulin administration, offering greater freedom and improved quality of life to users globally. Insulet serves a diverse international market, with availability in 25 countries and over 500,000 customers worldwide. Its commitment to advancing diabetes technology is supported by continuous research and development, aiming to refine and expand its product offerings. Insulet plays a significant role in the healthcare sector, particularly within the medical device industry, by providing cutting-edge solutions that address the complex needs of insulin-dependent individuals while emphasizing sustainability and social responsibility.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Insulet is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Insulet is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Insulet's data?

Create a free Tracenable account to signal interest in having our team review data for Insulet.

Legal Center Contact Us